Skip to content
Article Rich – Lifestyle
Author:
Asieris
2026 CSCCP-ASCCP Colposcopy Training Course–Wuhan Station Concludes, Promoting More Precise and Non-Invasive Management of Cervical Lesions
October 23, 2026
Asieris Pharmaceuticals Enters an Exclusive Licensing Agreement with Theramex for CEVIRA® subject to certain conditions, Advancing the Global Development and Commercialization of a Non-Surgical Treatment for Cervical Precancerous Lesions in Europe
October 7, 2026
Asieris Pharmaceuticals Releases 2026 Semi-Annual Report: Core Product Commercialization Delivers, Entering a Harvest Period as the Company Accelerates Its Transition to Biopharma
August 28, 2026